Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Neural Crest Cells Isolated from the Bone Marrow of Transgenic Mice Express JCV T-Antigen.

Gordon J, Sariyer IK, De La Fuente-Granada M, Augelli BJ, Otte J, Azizi SA, Amini S, Khalili K, Krynska B.

PLoS One. 2013 Jun 21;8(6):e65947. doi: 10.1371/journal.pone.0065947. Print 2013.

2.

Bone marrow-derived mesenchymal stem cells undergo JCV T-antigen mediated transformation and generate tumors with neuroectodermal characteristics.

Del Valle L, Piña-Oviedo S, Perez-Liz G, Augelli BJ, Azizi SA, Khalili K, Gordon J, Krynska B.

Cancer Biol Ther. 2010 Feb;9(4):286-94. doi: 10.4161/cbt.9.4.10653. Epub 2010 Feb 1.

3.
4.

Bag3-induced autophagy is associated with degradation of JCV oncoprotein, T-Ag.

Sariyer IK, Merabova N, Patel PK, Knezevic T, Rosati A, Turco MC, Khalili K.

PLoS One. 2012;7(9):e45000. doi: 10.1371/journal.pone.0045000. Epub 2012 Sep 12.

5.

Human neurotropic JC virus early protein deregulates glial cell cycle pathway and impairs cell differentiation.

Tretiakova A, Krynska B, Gordon J, Khalili K.

J Neurosci Res. 1999 Mar 1;55(5):588-99.

PMID:
10082081
6.

Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation.

Tan CS, Dezube BJ, Bhargava P, Autissier P, Wüthrich C, Miller J, Koralnik IJ.

J Infect Dis. 2009 Mar 15;199(6):881-8. doi: 10.1086/597117.

7.
8.

Oncogenic potential of human neurotropic papovavirus, JCV, in CNS.

Gordon J, Krynska B, Otte J, Houff SA, Khalili K.

Dev Biol Stand. 1998;94:93-101. Review.

PMID:
9776230
9.
10.

Cell type-specific expression of JC virus T antigen in primary and established cell lines from transgenic mice.

Beggs AH, Miner JH, Scangos GA.

J Gen Virol. 1990 Jan;71 ( Pt 1):151-64.

PMID:
2154532
11.

Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy.

Wüthrich C, Cheng YM, Joseph JT, Kesari S, Beckwith C, Stopa E, Bell JE, Koralnik IJ.

J Neuropathol Exp Neurol. 2009 Jan;68(1):15-25. doi: 10.1097/NEN.0b013e3181912570.

12.
13.

Frequent infection of cortical neurons by JC virus in patients with progressive multifocal leukoencephalopathy.

Wüthrich C, Koralnik IJ.

J Neuropathol Exp Neurol. 2012 Jan;71(1):54-65. doi: 10.1097/NEN.0b013e31823ede59.

14.

Evidence that the soluble factors secreted by activated immune cells suppress replication of human neurotropic JC virus DNA in glial cells.

Chang CF, Otte J, Kerr DA, Välkkilä M, Calkins CE, Khalili K.

Virology. 1996 Jul 1;221(1):226-31.

15.

Clonal immortalized human glial cell lines support varying levels of JC virus infection due to differences in cellular gene expression.

Ferenczy MW, Johnson KR, Steinberg SM, Marshall LJ, Monaco MC, Beschloss AM, Jensen PN, Major EO.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1303-19. doi: 10.1007/s11481-013-9499-8. Epub 2013 Sep 20.

PMID:
24052414
16.

Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals.

Krynska B, Otte J, Franks R, Khalili K, Croul S.

Oncogene. 1999 Jan 7;18(1):39-46.

17.
18.

JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy.

Tan CS, Ellis LC, Wüthrich C, Ngo L, Broge TA Jr, Saint-Aubyn J, Miller JS, Koralnik IJ.

J Virol. 2010 Sep;84(18):9200-9. doi: 10.1128/JVI.00609-10. Epub 2010 Jul 7.

19.

Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous system.

Del Valle L, Gordon J, Assimakopoulou M, Enam S, Geddes JF, Varakis JN, Katsetos CD, Croul S, Khalili K.

Cancer Res. 2001 May 15;61(10):4287-93.

20.

Human polyomavirus JC latency and reactivation status in blood of HIV-1-positive immunocompromised patients with and without progressive multifocal leukoencephalopathy.

Andréoletti L, Dubois V, Lescieux A, Dewilde A, Bocket L, Fleury HJ, Wattré P.

AIDS. 1999 Aug 20;13(12):1469-75.

PMID:
10465069

Supplemental Content

Support Center